Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilofer Azad

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Radiation Oncology (London, England)|September 26, 2012
ACR appropriateness criteria®  resectable rectal cancerWilliam E Jones, Charles R Thomas, Joseph M Herman, et al.
Oncology (Williston Park, N.Y.)|July 17, 2016
ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer, William Small, John P Hayes, et al.
American Journal of Clinical Oncology|September 16, 2015
ACR Appropriateness Criteria® Local Excision in Early Stage Rectal CancerSuzanne Russo, A William Blackstock, Joseph M Herman, et al.
Oncology (Williston Park, N.Y.)|October 18, 2014
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentationKaryn A Goodman, Sarah A Milgrom, Joseph M Herman, et al.
Gastrointestinal Cancer Research : GCR|February 22, 2014
ACR Appropriateness Criteria®-Anal Cancer, Theodore S Hong, Jennifer L Pretz, et al.
Oncology (Williston Park, N.Y.)|August 19, 2015
ACR Appropriateness Criteria® Resectable Stomach CancerParima Daroui, Salma K Jabbour, Joseph M Herman, et al.
American Journal of Clinical Oncology|December 20, 2013
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic CancerFarzana Faisal, Hua-Ling Tsai, Amanda Blackford, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancersChanghoon Yoo, Milind M Javle, Helena Verdaguer Mata, et al.
Future Oncology (London, England)|June 11, 2024
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTCNilofer Azad, Zishuo Hu, Ilyas Sahin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancerEric S Christenson, Won Jin Ho, Daniel Shu, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Radiation Oncology (London, England)|September 26, 2012
ACR appropriateness criteria®  resectable rectal cancerWilliam E Jones, Charles R Thomas, Joseph M Herman, et al.
Oncology (Williston Park, N.Y.)|July 17, 2016
ACR Appropriateness Criteria® Borderline and Unresectable Pancreas Cancer, William Small, John P Hayes, et al.
American Journal of Clinical Oncology|September 16, 2015
ACR Appropriateness Criteria® Local Excision in Early Stage Rectal CancerSuzanne Russo, A William Blackstock, Joseph M Herman, et al.
Oncology (Williston Park, N.Y.)|October 18, 2014
ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentationKaryn A Goodman, Sarah A Milgrom, Joseph M Herman, et al.
Gastrointestinal Cancer Research : GCR|February 22, 2014
ACR Appropriateness Criteria®-Anal Cancer, Theodore S Hong, Jennifer L Pretz, et al.
Oncology (Williston Park, N.Y.)|August 19, 2015
ACR Appropriateness Criteria® Resectable Stomach CancerParima Daroui, Salma K Jabbour, Joseph M Herman, et al.
American Journal of Clinical Oncology|December 20, 2013
Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic CancerFarzana Faisal, Hua-Ling Tsai, Amanda Blackford, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancersChanghoon Yoo, Milind M Javle, Helena Verdaguer Mata, et al.
Future Oncology (London, England)|June 11, 2024
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTCNilofer Azad, Zishuo Hu, Ilyas Sahin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2025
Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancerEric S Christenson, Won Jin Ho, Daniel Shu, et al.
Pageof 5